Development of Adoptive Cell Therapy for Cancer: A Clinical Perspective-Reference-Cited by-同舟云学术

Development of Adoptive Cell Therapy for Cancer: A Clinical Perspective

Published:2010-06 Issue:6 Volume:21 Page:665-672
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Hawkins Robert E.¹,Gilham David E.¹,Debets Reno²,Eshhar Zelig³,Taylor Naomi⁴,Abken Hinrich⁵,Schumacher Ton N.⁶

Affiliation:

1. Cellular Therapy Group, School of Cancer and Enabling Sciences, The Paterson Institute of Cancer Research, The University of Manchester, Manchester M20 4BX, United Kingdom.

2. Laboratory of Experimental Tumor Immunology, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, 3075EA Rotterdam, The Netherlands.

3. The Weizmann Institute of Science, Department of Immunology, 76100 Rehovot, Israel.

4. Institut de Génétique Moléculaire de Montpellier, 34293 Montpellier, France.

5. Klinik I für Innere Medizin and Zentrum für Molekulare Medizin Köln, Universitat zu Köln, 50931 Köln, Germany.

6. The Division of Immunology, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2010.086

Reference66 articles.

1. Antigen-specific targeting of CD28-mediated T cell co-stimulation using chimeric single-chain antibody variable fragment-CD28 receptors

2. Minimally Cultured or Selected Autologous Tumor-infiltrating Lymphocytes After a Lympho-depleting Chemotherapy Regimen in Metastatic Melanoma Patients

3. Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients

4. Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Trends and Innovative Approaches in Cancer Immunotherapy;AAPS PharmSciTech;2024-07-24

2. Advances in traditional herbal formulation based nano-vaccine for cancer immunotherapy: Unraveling the enigma of complex tumor environment and multidrug resistance;International Immunopharmacology;2024-05

3. Tumor microenvironment reprogramming by nanomedicine to enhance the effect of tumor immunotherapy;Asian Journal of Pharmaceutical Sciences;2024-04

4. Immune Cytolytic Activity and Strategies for Therapeutic Treatment;International Journal of Molecular Sciences;2024-03-23

5. Advancing rare disease treatment: EMA’s decade-long insights into engineered adoptive cell therapy for rare cancers and orphan designation;Gene Therapy;2024-03-14